A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis
Status:
Completed
Trial end date:
2003-07-01
Target enrollment:
Participant gender:
Summary
A 12-week trial consisting of 5 visits (6 if follow up is needed) to find out how effective
and safe three different doses of meloxicam are compared with placebo in Rheumatoid
Arthritis. Patient will take one dose of study medication daily.